1Campeau L, Enjalbert M, Lesperance J, et al. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years and 10 to 12 years after surgery. Circulation, 1983, 68(suppl II):II-1-II-7
2AllaireE,Clowes AW. Endothelial cell injury in cardiovascular surgery: the intimal hyperplasic response, Ann Thorac Surg, 1997,63:582～591
3Schwartz S.Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest , 1997 , 99 (12):814～817
5Aoyagi M, Yamamoto M, Azuma H , Nagashima G, Niimi Y, Tamaki M, et al.Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation. Histochem Cell Biol,1999, 109 (2) : 97～102
6Mason DP , Kenagy RD , Hasenstab D , BowenPope DF , Seifert RA , Coats S , et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery.Circ Res , 1999 , 85 (12) : 1 179～1185
8Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther. 1993 Sep;59(3):329～341
9Cheng L, Mantile G, Pauly R, Nater C, Felici A, Monticone R, Bilato C, Gluzband YA, Crow MT, Stetler-Stevenson W, Capogrossi MC. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation.1998;98:2195～2220
10George SJ, Baker AH, Angelini GD, Newby AC. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther.1998;5:1552～1560
